Publications — Radcliffe Department of Medicine

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern.

Ertesvåg NU. et al, (2022), Commun Med (Lond), 2

Two doses of SARS-CoV-2 vaccination induce more robust immune responses to emerging SARS-CoV-2 variants of concern than does natural infection.

Skelly DT. et al, (2021)

Protective porcine influenza virus-specific monoclonal antibodies recognize similar haemagglutinin epitopes as humans.

Holzer B. et al, (2021), PLoS Pathog, 17

Breadth and function of antibody response to acute SARS-CoV-2 infection in humans.

Huang K-YA. et al, (2021), PLoS Pathog, 17

A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses.

Tan TK. et al, (2021), Nat Commun, 12

Overcoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous Amidation

Rahikainen R. et al, (2021), Angewandte Chemie, 133, 325 - 334

Overcoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous Amidation.

Rahikainen R. et al, (2021), Angew Chem Int Ed Engl, 60, 321 - 330

Micro-fusion inhibition tests: quantifying antibody neutralization of virus-mediated cell-cell fusion.

Thakur N. et al, (2021), J Gen Virol, 102

Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient.

Zhou D. et al, (2020), Nat Struct Mol Biol, 27, 950 - 958

Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike.

Huo J. et al, (2020), Cell Host Microbe, 28, 445 - 454.e6

Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.

Huo J. et al, (2020), Nat Struct Mol Biol, 27, 846 - 854

Lung-targeting lentiviral vector for passive immunisation against influenza

TAN TK. et al, (2020), Thorax

Broadly Inhibiting Antineuraminidase Monoclonal Antibodies Induced by Trivalent Influenza Vaccine and H7N9 Infection in Humans.

Rijal P. et al, (2020), J Virol, 94

A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses

Tan TK. et al, (2020)

Structural characterisation of a nanobody derived from a naïve library that neutralises SARS-CoV-2

Huo J. et al, (2020)

Semaphorin 3A induces cytoskeletal paralysis in tumor-specific CD8+ T cells

Barnkob M. et al, (2019)

Broadly inhibiting anti-neuraminidase monoclonal antibodies induced by 1 trivalent influenza vaccine and H7N9 infection in humans

RIJAL P. and TOWNSEND A., (2019), Journal of Virology

Broadly inhibiting anti-neuraminidase monoclonal antibodies induced by trivalent influenza vaccine and H7N9 infection in humans

RIJAL P. and TOWNSEND A., (2019), Journal of Virology

Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans.

Rijal P. et al, (2019), Cell Rep, 27, 172 - 186.e7

A single cycle influenza virus coated in H7 haemagglutinin generates neutralizing antibody responses to haemagglutinin and neuraminidase glycoproteins and protection from heterotypic challenge.

Powell TJ. et al, (2019), J Gen Virol, 100, 431 - 445

Load More

Include forthcoming?